CBD decreased the cell viability of D425 and D283 medulloblastoma and IC-1425EPN and DKFZ-EP1NS ependymoma cell lines, independent of CB1, even though human medulloblastomas and ependymomas express CB1 and CB2 [45]. The gene discussed is CNR2; the disease is medulloblastoma.